Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway

Abstract Background Epiplakin1 (EPPK1) has been associated with disease progression and unfavorable prognosis of many cancers, but its functional involvement in esophageal squamous cell carcinoma (ESCC) remains to be uncovered. Methods The Quantitative Real‐time PCR (qPCR) assay was employed to dete...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhongshi Qiao, Chengcheng Dai, Zhiqian Wang, Zifan Wang, Zheng Wang, Tongsong Zhang, Wenjing Niu, Xuezhen Ma
Médium: Artigo
Jazyk:Inglês
Vydáno: Wiley 2022-04-01
Edice:Thoracic Cancer
Témata:
EPPK1
ESCC
PI3K/AKT pathway
tumor progression
On-line přístup:https://doi.org/10.1111/1759-7714.14366
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky